Fraunhofer Institute for Toxicology and Experimental Medicine

Fraunhofer Institute for Toxicology and Experimental Medicine

SOT 2026: Annual Meeting of the Society of Toxicology

Meet us from March 22 to 25, 2026, at the Annual Meeting of the Society of Toxicology and ToxExpo in San Diego. Visit us at our booth (booth no. 1235), meet us at our posters, or join us at our exhibitor-hosted session.

more info

© ORG, stock.adobe.com

Science Year 2026: Medicine of the Future

Research for precision medicine at Fraunhofer combines biological insights, digital technologies, and medical expertise to enable earlier disease detection and more individualized therapies. Here you can discover the projects and solutions through which Fraunhofer ITEM contributes to this federal initiative.

more info

© Fraunhofer

iGUARD receives Innovation Award

Researchers from Fraunhofer ITEM and MHH Receive the Lower Saxony Innovation Award 2025.

more info

© Marek Kruszewski/Niedersachsen.next Innovationsnetzwerk

EVape: Reliable Testing of E-Liquids under Controlled Conditions

Patented system from Fraunhofer ITEM increases consumer safety.

more info

© wolfhound911, stock.adobe.com

Fraunhofer ITEM receives AAALAC accreditation

Commitment to the highest standards in animal welfare.

more info

© Fraunhofer ITEM

Miniature Hearts: Cardiac Organoids With an Immune System

Multicellular human cardiac organoids for drug research.

more info

© Fraunhofer ITEM

Fraunhofer ITEM: News

Press Release / 16.3.2026

AveThera Acquires Fraunhofer ITEM's Braunschweig Location

Read Press Release

Press Release / 17.2.2026

Change in Management of the GLP Test Facility

Prof. Dr. Armin Braun has been appointed Head of the GLP Test Facility at Fraunhofer ITEM.

Read Press Release
 

© DLR

Press Release / 12.3.2026

Rocket Launch for StellarHeal

Milestone for Future Wound Care in Space Flights and on Earth.

Read Press Release

Press Release / 5.11.2025

“iGUARD” wins innovation award

Researchers from Fraunhofer ITEM and Hannover Medical School receive the Lower Saxony Innovation Award 2025.

Read Press Release

Press Release / 23.9.2025

Fraunhofer ITEM receives AAALAC accreditation

Commitment to the highest standards in animal welfare.

Read Press Release
 

© Timon, adobe.stock.com

News / 22.7.2025

Strengthening food safety in Europe

Fraunhofer ITEM is now an Article 36 organization of EFSA.

Read News

News / 17.7.2025

Birch Pollen Allergy

Joint publication with the German Environment Agency (UBA): New study defines threshold concentration for allergic reactions to birch pollen.

Read News

We keep you posted

For more than four decades, we have been developing solutions for human health

 

© Fraunhofer ITEM, Felix Schmitt

Lung research

Research for healthy lungs: Airway research has been a focus at Fraunhofer ITEM ever since the institute was founded. 

Read more
 

© Fraunhofer ITEM

Malignant disease research

The Fraunhofer ITEM Division of Personalized Tumor Therapy in Regensburg is aimed at understanding a patient’s individual condition, establishing appropriate diagnostics and optimizing therapies.

Read more

Bioinformatics and AI

Our researchers develop methods for preparation, analysis and visualization of biomedical data, as well as data models and data analysis pipelines. The focus is on the mapping of cellular and regulatory processes and their translation into applications.

Read more
 

© stock.adobe.com, CROCOTHERY

RNA technologies

RNA-based therapeutics are a drug class with huge potential for medicine. Fraunhofer ITEM researchers develop novel drugs and methods for RNA-based therapeutic concepts.

Read more
 

© Fraunhofer ITEM, Ralf Mohr

Stem cell technologies

Applying stem cell technologies and differentiated cell types for safety and efficacy testing.

Read more

Immunology and infection research

The development, formulation and mode of delivery of anti-infective agents, for example for inhaled administration as drug aerosols, are research topics of current interest at the institute.

Read more

Medical and pharmaceutical engineering

Next to innovative inhalation technologies, our focus is on developing novel technologies for administration of therapeutic aerosols by means of smart drug/device combination products.

Read more
 

© Fraunhofer ITEM, Ralf Mohr

Toxicology

Based on the next generation risk assessment concept, Fraunhofer ITEM develops new assessment strategies to provide predictive models for assessing the safety of compounds, active pharmaceutical ingredients and drugs.

Read more

Project archive

Here you can find more projects sorted by our research and development competences. 

Read More

Our services

 

© Fraunhofer ITEM, Ralf Mohr

Drug Development

From drug candidate to proof of concept:

Read more
 

© Fraunhofer ITEM

Chemical Safety and Assessment

From risk analysis towards safe products:

read more
 

© Fraunhofer ITEM

Translational Biomedical Engineering

From idea to safe medical device:

 

read more
 

© Fraunhofer ITEM, P. Reinig

Personalized Tumor Therapy

From molecular analysis to personalized therapy:

Read more
 

© Fraunhofer ITEM

Meet Fraunhofer ITEM at fairs and congresses

Event overview

Events

22.9.2026

3rd Fraunhofer CIMD Symposium RNA-Based Therapeutics

Save the date for the 3rd Fraunhofer CIMD Symposium RNA-Based Therapeutics at Fraunhofer ITEM in Hannover: September 22 and 23, 2026.
more info

22.3.2026

SOT Annual Meeting and ToxExpo 2026 in San Diego

We look forward to presenting our toxicological research at the Annual Meeting of the Society of Toxicology and ToxExpo in San Diego, California (USA). Visit us at our booth (booth number: 1235) or meet us at our posters or during our exhibitor-hosted session. We look forward to seeing you!
more info

17.3.2026

German Pharm-Tox Summit 2026

We are very pleased to contribute to the 11th German Pharm-Tox Summit with presentations and posters from our scientists.
more info

20.11.2025

Workshop Translational Human Tissue Models

We invite you to join us for our workshop, where we will explore and discuss cutting-edge model systems, the development of enabling technologies, and the implementation of alternative testing strategies.
more info

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of more than 70 institutes of the Fraunhofer-Gesellschaft, the world’s leading applied research organization. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research.

With a focus on respiratory research, the R&D portfolio at our Hannover headquarters comprises three business areas: Drug Development, Chemical Safety and Translational Biomedical Engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

 

More information about Fraunhofer ITEM